Overview
Gingivostomatitis is an inflammatory condition characterized by severe ulcerative and proliferative lesions affecting the gums and oral mucosa, often associated with significant pain, anorexia, and systemic immune dysregulation. It predominantly affects young children and cats, with human cases typically caused by herpes simplex virus type 1 (HSV-1) and feline cases often linked to immune-mediated mechanisms. The condition can lead to substantial morbidity, including dehydration, weight loss, and impaired quality of life, necessitating prompt and effective management to prevent complications and improve patient outcomes 1234.Pathophysiology
In humans, primary herpetic gingivostomatitis results from primary infection with HSV-1, leading to localized viral replication and subsequent immune activation. The virus enters oral mucosal cells, triggering a cascade of inflammatory responses characterized by neutrophil infiltration and cytokine release, which contribute to the ulcerative and proliferative lesions observed clinically 24. In cats, particularly those with feline chronic gingivostomatitis (FCGS), the pathophysiology is less clear but involves complex immune dysregulation, likely exacerbated by underlying dental disease, chronic antigenic stimulation, and possibly genetic predispositions. This immune-mediated component results in persistent oral inflammation despite dental interventions 1.Epidemiology
Acute gingivostomatitis in children is relatively frequent, with one case identified for approximately every 303 pediatric emergency department visits, predominantly affecting children under 36 months of age 3. In pediatric populations, the median age of affected children ranges from 2 to 2.7 years, indicating a higher incidence in early childhood. For feline gingivostomatitis, while specific incidence rates are not provided in the given sources, refractory cases are notable for their chronic nature and significant impact on affected cats, often requiring long-term management 1. Trends suggest an increasing awareness and reporting of cases, particularly in veterinary settings, but large-scale epidemiological studies are lacking.Clinical Presentation
Children with herpetic gingivostomatitis typically present with fever, oral ulcerations, painful swallowing, drooling, and significant feeding difficulties, often accompanied by systemic symptoms like lethargy and irritability 23. Red-flag features include severe dehydration, high fever, and signs of sepsis, necessitating urgent medical attention. In cats, clinical signs include severe oral pain, marked gingival hyperplasia, ulceration, and often extra-oral signs such as lethargy and weight loss, which can complicate diagnosis and management 1.Diagnosis
The diagnosis of gingivostomatitis involves a combination of clinical evaluation and supportive laboratory tests. Key diagnostic criteria include:
Clinical Symptoms: Presence of oral ulcerations, significant pain, and systemic signs (fever, dehydration in children).
Viral Detection: For herpetic gingivostomatitis in children, PCR testing of oral swabs or vesicular fluid for HSV-1 can confirm the diagnosis 2.
Dental Evaluation: In feline cases, thorough dental examination to rule out or confirm dental disease as a contributing factor 1.
Differential Diagnosis: Exclude other causes of oral ulcers such as aphthous stomatitis, Behçet's disease, and other viral infections (e.g., coxsackievirus) through clinical context and specific testing where applicable.Differential Diagnosis
Aphthous Ulceration: Typically presents with recurrent, smaller, well-defined ulcers without systemic symptoms 4.
Herpangina: Caused by enteroviruses, often seen in younger children with fever and small vesicles in the posterior oropharynx 3.
Hand, Foot, and Mouth Disease: Caused by enteroviruses, particularly Coxsackievirus A16 and Enterovirus 71, presenting with characteristic lesions on hands and feet 3.Management
Initial Management
Supportive Care: Ensure adequate hydration and nutrition. For children, oral rehydration solutions and soft, bland foods are recommended 23.
Pain Relief: Administer analgesics such as acetaminophen (15 mg/kg every 6-8 hours) or ibuprofen (5-10 mg/kg every 6-8 hours) for pain relief 4.Specific Therapy
Acyclovir: For herpetic gingivostomatitis in children, acyclovir (20 mg/kg/dose orally every 8 hours for 7-14 days) should be initiated within the first 72 hours of symptom onset if substantial pain or dehydration is present 2.
Topical Agents: Use of topical anesthetics like viscous lidocaine (maximum 1 mg/kg every 3-4 hours) or anti-inflammatory agents such as a mixture of Maalox and diphenhydramine for symptomatic relief 4.Refractory Cases
Feline Chronic Gingivostomatitis:
- Dental Extraction: Full-mouth extraction (FME) or partial-mouth extraction (PME) of diseased teeth 1.
- Mesenchymal Stem Cell Therapy: For refractory cases, allogeneic uterine-derived mesenchymal stem cells (UMSCs) administered intravenously may offer immunomodulatory benefits, though efficacy and safety require long-term monitoring 1.
- Immunosuppressive Therapy: Consider adjunctive use of corticosteroids or other immunosuppressive agents under specialist guidance, monitoring for potential side effects 1.Monitoring and Follow-Up
Regular reassessment of oral lesions and systemic symptoms.
Periodic viral load testing in herpetic cases to guide treatment duration 2.
For cats, ongoing evaluation of oral health and immune status, with adjustments to immunosuppressive therapy as needed 1.Complications
Children: Severe dehydration, secondary infections, and prolonged viral shedding 2.
Cats: Chronic pain, malnutrition, and systemic immune dysregulation leading to extra-oral manifestations 1.
Referral Indicators: Persistent symptoms despite initial management, signs of systemic illness, or complications such as sepsis warrant immediate referral to specialists 21.Prognosis & Follow-up
Children: Generally good prognosis with appropriate antiviral therapy and supportive care, though recurrent episodes can occur 2.
Cats: Variable prognosis, with refractory cases often requiring lifelong management and monitoring for chronic complications 1.
Follow-Up: Regular dental and oral health evaluations every 3-6 months for cats; pediatric follow-up should include monitoring for dehydration and nutritional status 12.Special Populations
Pediatrics: Focus on supportive care and early antiviral therapy to prevent dehydration and ensure adequate nutrition 234.
Cats: Special attention to dental health and immune modulation, with careful monitoring of response to stem cell therapy and immunosuppressive treatments 1.Key Recommendations
Initiate Acyclovir Therapy Early in children with herpetic gingivostomatitis if substantial pain or dehydration is present within the first 72 hours of symptom onset (Evidence: Strong 2).
Supportive Care is Essential, including hydration and pain management, for both pediatric and feline patients (Evidence: Moderate 231).
Consider Full-Mouth Extraction for cats with refractory gingivostomatitis after initial medical management fails (Evidence: Moderate 1).
Evaluate for and Manage Complications such as dehydration and secondary infections promptly (Evidence: Moderate 2).
Long-Term Monitoring is crucial for cats, especially those treated with stem cell therapy, to assess efficacy and safety (Evidence: Expert opinion 1).
Use Topical Analgesics like viscous lidocaine cautiously in children, adhering to dosing guidelines to minimize systemic absorption (Evidence: Moderate 4).
Refer Refractory Cases to specialists for advanced immunosuppressive therapies and further diagnostic workup (Evidence: Expert opinion 12).
Regular Oral Examinations for cats to monitor dental health and lesion progression are recommended (Evidence: Moderate 1).
Educate Owners on recognizing signs of relapse and the importance of adherence to prescribed treatments (Evidence: Expert opinion 1).
Consider Immunomodulatory Therapies like mesenchymal stem cells in refractory feline cases under strict veterinary supervision (Evidence: Weak 1).References
1 Williams VS, Schneider JL, Parrish RS, Thompson CM, Wrightson C, Taechangam N et al.. Long-term field safety study evaluating allogeneic, uterine-derived mesenchymal stem cells for refractory feline chronic gingivostomatitis. Journal of feline medicine and surgery 2026. link
2 Goldman RD. Acyclovir for herpetic gingivostomatitis in children. Canadian family physician Medecin de famille canadien 2016. link
3 de Suremain N, Guedj R, Fratta A, Franclin A, Loschi S, Aroulandom J et al.. Acute gingivostomatitis in children: Epidemiology in the emergency department, pain, and use of codeine before its restriction. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2019. link
4 Faden H. Management of primary herpetic gingivostomatitis in young children. Pediatric emergency care 2006. link